| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9404690 | Surgery | 2005 | 6 Pages |
Abstract
This study demonstrates that reduced expression of tuberin might be involved in the progression of pancreatic cancer. Accordingly, tuberin may provide a new therapeutic target in patients with this type of cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
Kozo Kataoka, Koji MD, PhD, Daisuke MD, Masayuki MD, Eiji MD, Tomohiko MD, Kazuhiro MD, Ryuichiro MD, PhD,